We hypothesize that HER2 may be involved in radioresistance and measuring of HER2-expression as a response to external irradiation may be used to monitor treatment response in PCa for the stratification of patients and their response to additional therapy. The gene discussed is ERBB2; the disease is posterior cortical atrophy.